HeLa Signaling Cascade Whole Cell Lysate Set: PMA-Treated and Vehicle-Treated Control
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Supplier Data
Western blot - HeLa Signaling Cascade Whole Cell Lysate Set: PMA-Treated and Vehicle-Treated Control (AB170195)
Western Blot Validation.
HeLa cell cultures were serum-starved overnight and treated with 200nM of PMA for 1 hour at 37°C. 40μg of cell lysate was run on a 4-20% gradient gel then transferred to a PVDF membrane. All blocking and antibody incubation steps were done in 5% milk, 20 mM Tris-HCl, 0.1% TWEEN-20. Primary antibodies : RSK1p90 total : 1 : 1000 ab32114 RSK1p90 pSer380 : 1 : 500 ab32203 Actin beta : 1μg/mL ab8226 Secondary antibodies : Goat polyclonal to Mouse IgG – H&L – Pre-Adsorbed (HRP) at 1/10000. Goat polyclonal to Rabbit IgG – H&L – Pre-Adsorbed (HRP) at 1/10000.
false
- SDS-PAGE
Supplier Data
SDS-PAGE - HeLa Signaling Cascade Whole Cell Lysate Set: PMA-Treated and Vehicle-Treated Control (AB170195)
Optiblot Blue stain HeLa cell cultures were serum-starved overnight and treated with 200 nM of PMA for 1 hour at 37°C. 40 μg of cell lysate was run on a 4-20% gradient gel then stained with Optiblot Blue (ab119211) for 2 hours at room temperature. Gel was destained using nanopure water for 24 hours.
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
HeLa cells are an adherent human epithelial cell line derived from a cervical carcinoma. HeLa cells were lysed with 1% SDS in the prescence of protease and phosphatase inhibitors. Protein concentration of the extract was determined by BCA assay. The extract is suitable for use in SDS-PAGE and Western blotting.
PMA-treated HeLa lysate is designed for use as a western blot positive control when studying signaling cascades downstream of PKC. Cells were treated with 200 nM PMA for 1 hour after overnight serum starvation. Untreated cells were grown under the same conditions and treated instead with DMSO (PMA diluent as used to generate the treated lysate).
Concentration: HeLa PMA-treated lysate, 200 μg at 2.0 mg/mL
HeLa DMSO-treated lysate, 200 μg at 2.0 mg/mL
PMA (phorbol 12-myristate 13-acetate) also known as TPA (12-O-Tetradecanoylphorbol 13-acetate), is a potent activator of protein kinase C (PKC), a calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase. PKC is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com